Previous 10 | Next 10 |
Penny Stocks To Watch Before November One of the most consistently resilient industries in the stock market today is biotech. With that penny stocks have played a relatively larger role especially this year. The coronavirus has also had a hand in propelling a number of these small-c...
Gainers: vTv Therapeutics (VTVT) +22%, Forte Biosciences (FBRX) +20%, Penumbra (PEN) +14%, Cellect Biotechnology (APOP) +10%, Inari Medical (NARI) +10%.Losers: Tricida (TCDA) -52%, Cancer Genetics (CGIX) -34%., Constellation Pharmaceutica...
HIGH POINT, N.C., Oct. 29, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that it will make an oral presentation at the 13 th Clinical Trials on Alzheimer’s Disease (CTAD) Digital Event on November 4, 2020. The presentation will provide a genera...
Kubient KBNT -21% on Q2 2020 Results Earnings call.Nikola NKLA -12% after WSJ warns on stalled talks with potential partners.NanoVibronix (NAOV) -10%.Golar LNG (GLNG) -9%.Digital Ally (DGLY) -8%.DiamondPeak Holdings (DPHC) -8%.AIM ImmunoTech (AIM) -7%.Pen...
SPI Energy (SPI) +56% after launching new EV Company.MediciNova (MNOV) +36% on positive intranasal COVID-19 vaccine data.vTv Therapeutics (VTVT) +20% on positive clinical study results supporting the safety and efficacy of TTP399.Athersys (ATHX) +13% af...
VTv Therapeutics (VTVT) jumps 14% premarket after announcing data from the completed Phase 2 Simplici-T1 study that support the clinical potential of TTP399 as an oral adjunctive therapy in type 1 diabetes (T1D).The data suggests that TTP399 does not increase the risk of diabetic ke...
HIGH POINT, N.C., Sept. 23, 2020 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) yesterday presented data from the completed Phase 2 Simplici-T1 study ( NCT03335371 ) that support the clinical potential of TTP399 as an oral adjunctive therapy in type 1 diabetes (T1D). ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead Tesla (NASDAQ:TSLA) will take top billing this week with its highly-anticipated Battery Day event ...
Volatility watch: Short interest has been in an uptrend for Vale (NYSE: VALE ) and Barrick Gold (NYSE: GOLD ) , while Tootsie Roll Industries (NYSE: TR ) and Signet Jewelers (NYSE: SIG ) stand out on the list of stocks with the highest percentage of short interest as total float. M...
Pity is the most agreeable feeling among those who have little pride and no prospects of great conquests. "― Friedrich Nietzsche Today, we take an in depth look at a small developmental company that comes up from time to time in comments. The stock also sees large purchases of stoc...
News, Short Squeeze, Breakout and More Instantly...
vTv Therapeutics Inc. Company Name:
VTVT Stock Symbol:
NASDAQ Market:
vTv Therapeutics Inc. Website:
HIGH POINT, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late stage biopharmaceutical company with an innovative clinical portfolio of small molecules and lead program in diabetes, today announced that the United States Food and Drug Administration (FDA) has pla...
2024-06-26 16:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Cadisegliatin is a potential first-in-class oral liver selective glucokinase activator for T1D, which has been granted Breakthrough Therapy designation by the FDA for T1D Cadisegliatin has been dosed in over ...